Genmab — Juni 2018
-
Jeps.
-
Genmab: For tidligt at afskrive Darzalex i solide tumorer
Trods et afbrudt studie med Genmabs kræftmiddel Darzalex mod lungekræft advarer topchef Jan van der Winkel mod helt at afskrive midlet.
(medwatch.dk)
-
God morgen
-
God morgen.
-
God morgen
-
@bibob - at du er i Malaga forsvarer din tidlige brandert i går
-
God morgen
Herligt med en grøn udsigt -
Det er vist 1.020 som er modstanden i følge Solsen.
-
Men herligt at se AB være køber her fra morgen af
Hvis Nordnetterne så ville lade vær med at sælge -
Ray Comenzo, MD, Discusses ANDROMEDA Trial in AL Amyloidosis Patients https://www.raredr.com/news/ray-comenzo-md-discusses-andromeda-trial-al-amyloidosis-patients
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind